Connect with us

Politics

Where Presidential Candidate Elizabeth Warren Stands On Marijuana

Published

on

Sen. Elizabeth Warren (D-MA) announced on February 9, 2019 that she was running for the 2020 Democratic presidential nomination, and she suspended her campaign on March 5, 2020.

While Warren is widely known as an advocate for consumer protections and Wall Street regulation, she’s also developed a reputation as a champion for modernizing marijuana laws. As such, she has an A grade from NORML.

That wasn’t always the case, as the senator was previously somewhat dismissive of cannabis reform attitudes, and declined to endorse her home state of Massachusetts’s legalization ballot measure ahead of Election Day 2016—but her position quickly evolved as public opinion on the issue shifted demonstrably in favor of reform, particularly among Democratic primary voters.

This piece was last updated on March 6, 2020 to include the candidate’s statements and policy actions on marijuana since joining the race. It will continue to be updated on a rolling basis.

Legislation And Policy Actions

Warren is the lead sponsor of the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act, which she filed in partnership with Sen. Cory Gardner (R-CO) in April 2019 as well as an earlier version in June 2018. The legislation would amend the Controlled Substances Act (CSA) to exempt state-legal marijuana activity from federal interference and is also aimed at addresses banking access issues for the cannabis industry.

The senator has co-sponsored several other major pieces of cannabis reform legislation. That includes two wide-ranging bills from Sen. Cory Booker (D-NJ): the CARERS Act, which was designed to protect medical marijuana patients from federal enforcement efforts and stimulate research into the plant, and the Marijuana Justice Act, which would remove marijuana from the CSA and direct federal courts to expunge the criminal records of those previously convicted of a cannabis-related offense. The latter bill also goes beyond the regular “states’ rights” mantra long expressed by reformers on Capitol Hill by actually withholding funding from states that maintain discriminatory enforcement of marijuana laws.

A more recent bill from House Judiciary Chairman Jerry Nadler (D-NY) and Sen. Kamala Harris (D-CA) that would deschedule cannabis and reinvest in communities disproportionately impacted by prohibition also received her cosponsorship.

Warren also signed onto a marijuana descheduling bill introduced by Sen. Chuck Schumer (D-NY) this Congress and last.

During the 115th Congress, she cosponsored legislation to encourage the Department of Veterans Affairs (VA) to conduct research into the therapeutic potential of cannabis for veterans.

In 2019, Warren signed onto stronger legislation that would require VA to study medical cannabis.

She also teamed up with Gardner in December 2019 to introduce bills aimed at protecting military veterans and immigrants from being punished for working at state-legal cannabis businesses.

“Veterans have sacrificed so much for us,” she said of the legislation. “But our outdated federal marijuana laws prevent vets who work in their state’s legal cannabis industry from getting a VA-backed home loan to realize the dream of homeownership. I have a bipartisan bill for that.”

Additionally, she co-sponsored three bills aimed at providing banking access to marijuana businesses: the SAFE Banking Act in 2017 and 2019 and the Marijuana Businesses Access to Banking Act in 2015.

Warren has not had the opportunity to vote on any marijuana bills or amendments during her time in the Senate.

The senator led a letter directed to the DEA in December 2019, demanding an update on the agency’s efforts to increase the number of federally authorized cannabis manufacturers for research purposes. The letter also inquired about the prospects of rescheduling the plant.

In March 2017, Warren signed a letter expressing concern about remarks from then-White House Press Secretary Sean Spicer, who hinted at a federal crackdown on legal cannabis states. The letter encouraged the Justice Department to allow states to operate legal cannabis systems without fear of federal intervention.

In November 2017, the senator wrote a letter to Trump’s then-nominee to head up the Department of Health and Human Services, Alex Azar. In the letter, she said the administration should consider legalizing cannabis as a means to combat the opioid epidemic, citing research indicating the legal states experience lower rates of opioid overdoses compared to non-legal states.

And in January 2018, she sent a letter with a bipartisan coalition co-signers imploring Trump to direct former Attorney General Jeff Sessions to reinstate the Cole memo, an Obama-era document providing guidance on federal marijuana enforcement. Doing so would “create a pathway to more comprehensive marijuana policy that respects state interests and prerogatives,” the lawmakers wrote.

On The Campaign Trail

In February, 2020, Warren released a detailed marijuana-focused plan that includes promises to begin the federal cannabis legalization within 100 days of taking office, involve communities harmed by the drug war in the marijuana industry, respect other nations’s drug laws and allow Washington, D.C. to enact legal sales.

Warren’s earlier criminal justice reform plan, which was released in August 2019, calls for the legalization of cannabis and safe injection facilities where people can use illicit drugs in a medically supervised environment.

She has pledged to deschedule cannabis through executive action if elected.

The candidate released a plan for veterans in November 2019 that emphasizes her support for “legislation to study the use of medical cannabis to treat veterans as an alternative to opioids, because we need to pursue all evidence-based opportunities for treatment and response.”

She also issued a plan for Native Americans that calls for tribal marijuana programs to be protected against federal intervention, and later cited her cannabis reform work in a lengthy letter responding to ongoing criticism from tribal members about how she has characterized her own heritage.

During a Democratic debate in February, she said that rival candidate Pete Buttigieg did not adequately explain racial disparities in marijuana arrests that took place during his time as mayor of South Bend, Indiana.

“You have to own up to the facts. And it’s important to own up to the facts about how race has totally permeated our criminal justice system,” she said. “We need to rework our criminal justice system from the front end on what we make illegal all the way through the system and how we help people come back into the community.”

At a campaign stop in Iowa in March, 2019, Warren said that “it’s just time to legalize [marijuana] nationally.”

After President Donald Trump’s former campaign manager Paul Manafort was sentenced to 47 months in prison for bank and tax fraud, Warren compared it to a case of a homeless man receiving a life sentence over $20 worth of cannabis.

“The words above the Supreme Court say ‘Equal Justice Under Law’—when will we start acting like it?” she wrote.

Warren criticized a budget proposal from Trump that would revoke current protections for state medical cannabis laws.

Warren touted endorsements for her STATES Act from the governors of Massachusetts, California and other states, writing that her legislation is “long overdue.”

“Our federal marijuana laws perpetuate our broken criminal justice system, impede research, restrict veterans’ access & hinder economic development,” Warren said. “Marijuana should be legalized, & I’ll work with anyone – GOP, Dem, Independent, Libertarian, vegetarian – to push for these reforms.”

“Let’s be clear: Our government criminalizes too many things and sends too many people to jail,” she said in November, including marijuana legalization in a list of policies she’ll push for.

Warren discussed racial disparities in marijuana law enforcement at a CNN town hall event in April and took a question from a voter who challenged her on the fact that she hasn’t always supported cannabis reform.

“I supported Massachusetts changing its laws on marijuana,” she said, setting aside the fact that she did not actually endorse several cannabis measures her state’s voters approved over the years. “Massachusetts had decriminalized at that point and I thought it made a lot more sense for Massachusetts to go ahead and legalize marijuana, and I now support the legalization of marijuana.”

In December 2019, a top aide on Warren’s campaign told Marijuana Moment that a claim being circulated that her team rejected a job applicant over a cannabis offense was false.

Ahead of a National Cannabis Industry Association conference in Boston in January 2020, Warren sent a letter welcoming the group to her home state.

The senator told America Quarterly that Latin American countries legalizing marijuana or other drugs would not undermine U.S. interests

“The ‘War on Drugs’ has criminalized addiction, destabilized the region, and failed to significantly curb violent effects of the drug trade. It has not made us safer,” she said. “I support the legalization of marijuana. It’s time for a new approach that emphasizes evidence-based treatment while reducing and preventing criminal violence.”

The senator contributed an essay for a publication on criminal justice issues that touches on broader reforms she wants to enact.

“We should legalize marijuana and wipe clean the records of those who have been unjustly jailed for minor marijuana crimes; end private prisons and the profit incentives that pervert the goal of our justice system; provide more help for people struggling with domestic abuse, substance use disorders, and mental illness; and end the practice of branding the formerly incarcerated with a scarlet letter that closes doors to education, employment, and opportunity,” she wrote.

Previous Quotes And Social Media Posts

Warren has tweeted her views on marijuana policy on numerous occasions, and her office has released several statements and press releases about the issue.

“Outdated federal marijuana laws have perpetuated our broken criminal justice system, created barriers to research, and hindered economic development,” Warren said in a press release when filing the STATES Act. “States like Massachusetts have put a lot of work into implementing common sense marijuana regulations – and they have the right to enforce their own marijuana policies. The federal government needs to get out of the business of outlawing marijuana.”

“Forcing legitimate marijuana businesses to operate a cash-only business is dangerous,” she said in a press release about cannabis banking legislation. “It creates unnecessary public safety issues for communities and business owners. The SAFE Banking Act is a common sense bill that would advance state efforts to regulate the sale of marijuana and support businesses working to establish reliable business operations.”

“Another option to tackle the opioid crisis is to invest in more research on alternative pain therapies, including physical therapy and new drugs that don’t have abuse potential,” Warren said during a 2016 hearing of the Senate Special Committee on Aging. “Medical marijuana might also be a viable alternative, but the truth is we just don’t know,” she said, noting the barriers to research that exist due to federal prohibition.

“The best studies suggest that African Americans and whites use marijuana at the same rates, but African Americans are twice as likely to be arrested for [it] than whites,” she said during a campaign appearance in New Hampshire. How about we legalize marijuana and get rid of all those cases?”

In another campaign stop Warren said she “voted in favor of legalizing marijuana in Massachusetts” and that she believes “we should legalize it nationally.”

Warren’s 2018 Senate reelection website included a marijuana petition as a list-building tactic.

“Our current marijuana policies are unjust and they don’t make sense. That’s why I’m fighting for reform,” it says. “Add your name to join the fight.”

Her current presidential campaign website highlights her work on marijuana in a few places.

One page meant to push back against the idea that she is “too partisan to get things done” touts her “bipartisan bill to end the federal ban on marijuana – allowing states, territories, and tribes to set their own policies on legalization, decriminalization, and medical marijuana.”

“There’s a lot more to do to reform our marijuana laws, but letting states make their own choices would be a powerfully important start – and it’s something Democrats and Republicans agree on,” the site says.

Another page addressing issues related to her heritage and criticisms of how she has framed it cites Warren’s legislation as a way to “ensure that our country’s cannabis policies don’t leave Indian Country behind.”

“For many Native tribes, cannabis represents an important opportunity for economic development, and for some it has cultural or medicinal importance,” the site says. “Elizabeth introduced the STATES Act with Colorado Republican Senator Cory Gardner to safeguard the ability of states, territories, and tribes to decide how to enforce their own marijuana policies. The STATES Act – and especially its important tribal provisions – has received strong support from Indian Country.”

Another page says that “it’s not equal justice when a kid with an ounce of pot can get thrown in jail while a bank executive who launders money for a drug cartel can get a bonus.”

“We need criminal justice reform and we need it now,” the site says. “That means ending racial disparities in our justice system. It means banning private prisons. It means embracing community policing and demilitarizing our local police forces. It means comprehensive sentencing reform and rewriting our laws to decriminalize marijuana.”

The senator hasn’t always been receptive to broad reform:

In 2003, Warren suggested that the profits in tax revenue from legal marijuana could be outweighed by the consequences, writing in a book that “drug addiction, health problems, traffic accidents, and so forth” represent the “downside of marijuana.”

The candidate tried to use the pro-legalization stance of former Massachusetts Rep. Dan Winslow (R) against him as he sought the Republican nomination for U.S. Senate in 2013. She said, “I advise everyone to pay very close attention to Dan Winslow’s platform. He has a 100 percent ranking from the gun lobby and he’s for the legalization of marijuana. He wants us armed and stoned.”

In 2011, Warren voiced opposition to marijuana legalization for recreational purposes, stating that medical cannabis “is one thing,” but she’s not “generally” supportive of broader reform.

She also angered some cannabis reform advocates by staying on the sidelines of Massachusetts’s 2016 legalization ballot campaign, coming only so close as to say she “would be open to the possibility of legalizing marijuana in Massachusetts” prior to Election Day.

But that didn’t stop her from later falsely stating that she actually endorsed the measure.

“Yes, I did,” she said earlier this year. “Oh, I did.”

While the senator later clarified that she voted in favor of the measure in the privacy of the voting booth, that explanation fell far short of what Bay State advocates were hoping to see from their progressive senator.

Personal Experience With Marijuana

Warren said in a 2018 interview that she has never smoked marijuana.

Marijuana Under A Warren Presidency

Warren’s evolution on cannabis issues over the past two years has transformed her into one of Congress’s leading advocates for ending federal prohibition, a stance she would be expected to take with her into the Oval Office if she’s elected.

High-Ranking House Democrat Calls On Congress To Decriminalize Marijuana As ‘Next Step’

Photo element courtesy of Gage Skidmore.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE and attn.

Politics

United Nations To Vote On Marijuana Rescheduling And CBD Issues This Week, With U.S. Backing Some Reforms

Published

on

A key United Nations (UN) commission will vote on a series of World Health Organization (WHO) recommendations concerning international marijuana reform this week. And the U.S. is in favor of the boldest policy change.

UN’s Commission on Narcotic Drugs (CND) has held numerous meetings on the proposals—including removing cannabis from the most restrictive global drug scheduling category under a global treaty—since WHO made its six recommendations last year. Now, after several delays, CND is finally scheduled to meet to decide on the measures on Wednesday.

Advocates are generally encouraged by the development, arguing that a vote in favor of the reforms will promote research into the therapeutic potential of cannabis. However, they say removing marijuana from its current international Schedule IV status does not go far enough and means that many member nations will continue to criminalize the plant.

Here are each of WHO’s cannabis recommendations:

1. Remove marijuana from Schedule IV of the 1961 Single Convention.

2. Add THC and dronabinol (synthetic THC medication) to Schedule I of the 1961 Convention and, if approved, delete them from Schedule II of the 1971 Convention.

3. If the second recommendation is adopted, add tetrahydrocannabinol to Schedule I of the 1961 Convention and, if approved, delete it from Schedule I of the 1971 Convention.

4. Delete “extracts and tinctures of cannabis” from Schedule I of the 1961 Convention.

5. Add footnote to clarify that CBD products containing no more than 0.2 percent THC are not subject to international control.

6. Add “preparations containing dronabinol” to Schedule III of the 1961 Convention.

Last month, the U.S. government said it is backing the WHO recommendation to remove marijuana from the most restrictive global drug scheduling category—though it’s opposing separate cannabis reform proposals, including the one to clarify that CBD is not under international control.

John Walsh, director of drug policy for Washington Office on Latin America (WOLA), told Marijuana Moment that this upcoming vote is “momentous,” especially as “this is the first time that the UN scientific bodies has assessed placing cannabis and drug control schedules.”

‘And it’s extremely significant that the United States is supporting a recommendation to remove cannabis from Schedule IV, which strongly discourages medical uses of cannabis, even if it doesn’t outright prohibit it,” he said.

Of principal concern to advocates is that while marijuana would be removed from Schedule IV under the 1961 Single Convention—the most strict international category—it would maintain its status as a Schedule I controlled substance if the panel accepts the recommendation. (The international scheduling system differs from that of the U.S. in that the country’s most restrictive category is Schedule I.)

But despite supporting that recommendation, the U.S. circulated a proposed joint statement to other member states that claims consensus on the notion “that cannabis is properly subject to the full scope of international controls of the 1961 Single Convention, due in particular to the high rates of public health problems arising from cannabis use and the global extent of such problems, as identified in the critical review by WHO.”

It also stipulates that “no Party shall be precluded from adopting measures of control more strict or severe than those required as a result of this decision, if such measures in its opinion are necessary or desirable for the protection of the public health or welfare.” The language seems to attempt to leave room for countries to continue enforcing more restrictive cannabis policies regardless of international rules.

In an email obtained by Marijuana Moment, a State Department official said that the U.S. “believes, to demonstrate unity, every CND member and observer could ideally join the statement below, regardless of how their government will vote.” They also plan to proceed with filing the statement even if no other member states join them.

The statement represents a “disconnect” from the country’s planned vote in favor of removing marijuana from the international body’s most restrictive drug classification, Walsh said.

“Civil society had called for, and welcomed, this long overdue review process—but many have been critical of some of the recommendations,” drug policy reform advocates said in a media advisory. “While recommendations on medical cannabis and CBD are certainly positive steps, profound concerns have been raised around leaving cannabis in Schedule I of the 1961 Convention.”

“This recommendation is at odds with The Who Expert Committee on Drug Dependence’s clear finding that cannabis was less harmful than other drugs included in that schedule (heroin and cocaine),” the advisory, prepared by advocacy groups Transform Drug Policy Foundation, Transnational Institute, International Drug Policy Consortium and WOLA, said.

“Regardless of the outcome of the votes on 2 December, this historic review process has demonstrably failed to implement a much-needed modernization of an outdated and malfunctioning system, and to resolve key scientific, political, institutional and human rights challenges related to cannabis and its status in the international drugs control system,” they said.

Numerous health and drug policy reform groups have advocated for the more modest changes WHO proposed.

A coalition of drug policy groups told member nations in a sign-on statement that patients worldwide are “counting on you to seize the opportunity offered by WHO to update the treaties, doing all you can to ensure access to all useful medicines. Including cannabis medicines.”

“Adopting WHO’s recommendations would lead to better medications being developed and more tools for doctors to alleviate suffering while simultaneously reinforcing the UN’s relevance,” they said.

The Multidisciplinary Association for Psychedelic Studies also weighed in in favor of the recommendations.

While the WHO’s CBD recommendation would simply offer clarification that cannabidiol products containing no more than 0.2 percent THC isn’t a controlled substance under international treaties, the U.S. came down against that and several other cannabis-related proposals.

It should be noted that none of WHO’s recommendations would promote the legalization of cannabis in any country, but advocates nonetheless seem that as a step forward from the status quo.

“This is super, super meaningful. But I don’t want to overstate it,” Michael Krawitz, a U.S. Air Force veteran and legalization advocate who has spent years working to reform international drug treaties, told Marijuana Moment. “I’ve been cautioning really hard to member states to not fall into this trap that the opposition fell into on [on California’s 1996 medical cannabis initiative] of overstating what this does in an effort to try to stop it—and then vicariously creating expectations in people’s minds that this actually does much more than it does.”

But the U.S.’s expected support for the proposal to remove marijuana from Schedule IV represents a departure from its position as articulated in a government document that Marijuana Moment obtained earlier this year. The document stated that it’s “possible that civil society, the media, and the general public will view deleting cannabis from Schedule IV as a first step toward widespread legalization of marijuana use, especially without proper messaging.”

Meanwhile, if the recommendation on CBD is adopted, it could potentially have far-reaching implications in the U.S. In 2018, the FDA determined that CBD does not meet the criteria for federal control—except for the fact that international treaties to which the U.S. is party could potentially be construed as requiring it.

The U.S. does intend to back the fourth WHO recommendation on deleting cannabis extracts and tinctures from Schedule I of the 1961 Convention, according to advocates familiar with the delegation’s thinking.

FDA has on several occasions solicited public input to shape the government’s position on the international scheduling of marijuana and cannabinoids. The agency initially requested feedback on the proposal in March 2019 and then reopened that comment period five months later.

House Leaders Propose Changes To Federal Marijuana Legalization Bill Up For Floor Vote This Week

Photo by Aphiwat chuangchoem.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

House Leaders Propose Changes To Federal Marijuana Legalization Bill Up For Floor Vote This Week

Published

on

A key House committee has scheduled a Wednesday hearing to advance a bill to federally legalize marijuana toward a full floor vote, which could then happen as soon as Thursday. Meanwhile, leaders in the chamber are proposing an amendment that would make several changes to the cannabis legislation.

Among the most significant revisions would be to the tax-related provisions of the bill.

The Rules Committee’s move to take up the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act follows Majority Leader Steny Hoyer (D-MD) announcement that the chamber would be holding a floor vote on the bill before the end of the year.

Judiciary Committee Chairman Jerrold Nadler (D-NY), the lead sponsor of the bill, transmitted it to Rules with the series of modifications—many of them technical in nature. But beyond the tax changes, the newly proposed language also reaffirms the regulatory authority of certain federal agencies such as the Food and Drug Administration (FDA) and clarifies that cannabis can still be included in drug testing programs for federal workers.

Other members of the House are likely to file proposed amendments as well, though the Democratic majority of the Rules panel will determine which ones can be made in order for floor votes later this week.

As originally drafted, the legislation would have imposed a five percent tax on marijuana products, revenue from which would be used in part to fund a grant program to support communities disproportionately impacted by the war on drugs. In Nadler’s amendment, that language is being removed and replaced with text that more closely reflects a separate descheduling bill, the Marijuana Revenue and Regulation Act.

The modified tax provisions of the MORE Act would make it so cannabis would be federally taxed at five percent for the first two years after implementation and then increased by one percent each year until reaching eight percent. After five years, taxes would be applied to marijuana products based on weight rather than price.

At its core, the MORE Act would federally deschedule cannabis from the Controlled Substances Act and expunge the records of those with prior marijuana convictions. The descheduling provisions would be retroactive.

The bill would also create a pathway for resentencing for those incarcerated for marijuana offenses, as well as protect immigrants from being denied citizenship over cannabis and prevent federal agencies from denying public benefits or security clearances due to its use.

A new Cannabis Justice Office under the Justice Department would be responsible for distributing funds providing loans for small cannabis businesses owned and controlled by socially and economically disadvantaged individuals. The bill also seeks to minimize barriers to licensing and employment in the legal industry.

While the bill still calls for the establishment of a Community Reinvestment Grant Program, the new leadership amendment would remove a line calling for it to specifically fund “services to address any collateral consequences that individuals or communities face as a result of the War on Drugs.”

Tax dollars appropriated to that program would instead more generally go to job training, legal aid for criminal and civil cases such as those concerning marijuana-related expungements, literacy programs and youth recreation and mentoring services, among other programs.

The definition of people impacted by the drug war who could be eligible for aid is also being changed to narrow the scope. At first it included those who have “been arrested for or convicted of the sale, possession, use, manufacture, or cultivation of cannabis or a controlled substance,” but now it only extends to marijuana and not other illicit drugs.

Other changes included in Nadler’s latest revision include one requiring FDA and the U.S. Department of Health and Human Services (HHS) to hold public meetings on “regulation, safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds” within one year of the bill’s enactment.

The language is also being updated to reflect the current number of states where marijuana is legal for medical or recreational purposes, clarify that FDA and HHS maintain their authorities to regulate cannabis products and stipulate that federal agencies can continue to include cannabis in employee drug testing. A conforming amendment would clarify that the U.S. Department of Transportation could continue to require drug testing for workers in safety sensitive positions.

The revised version also stipulates that funding can be made available to “connect patients with substance use disorder services” and apply to “individuals who have been arrested for or convicted of the sale, possession, use, manufacture, or cultivation of a controlled substance other than cannabis (except for a conviction involving distribution to a minor).”

The proposal also deletes from the definition of substance misuse treatment language stating that it would be an “evidence-based, professionally directed, deliberate, and planned regimen including evaluation, observation, medical monitoring, harm reduction, and rehabilitative services and interventions such as pharmacotherapy, mental health services, and individual and group counseling, on an inpatient or outpatient basis, to help patients with substance use disorder reach remission and maintain recovery.”

There are also a number of technical and conforming changes in the proposal, as well as the removal of the word “most” from “individuals most adversely impacted by the War on Drugs” when it comes to determining eligibility for the new programs and services created by the legislation.

In a new report on the bill that was submitted by the Democratic majority in Judiciary, members said cannabis enforcement “has been a key driver of mass criminalization in the United States” and the “drug war has produced profoundly unequal outcomes across racial groups, manifested through significant racial disparities throughout the criminal justice system.”

“The higher arrest and incarceration rates for communities of color do not reflect a greater prevalence of drug use, but rather the focus on law enforcement on urban areas, lower income communities, and communities of color,” they wrote.

Further, the “collateral consequences of even an arrest for marijuana possession can be devastating, especially if a felony conviction results.”

“Those arrested can be saddled with a criminal conviction that can make it difficult or impossible to vote, obtain educational loans, get a job, maintain a professional license, secure housing, secure government assistance, or even adopt a child,” the report states. “These exclusions create an often-permanent second-class status for millions of Americans. Like drug war enforcement itself, these consequences fall disproportionately on people of color. For non-citizens, a conviction can trigger deportation, sometimes with almost no possibility of discretionary relief.”

Rep. Jim Jordan (R-OH), GOP ranking member on the panel, wrote the minority opinion in the report.

He argued that the MORE Act “disregards established science” and “would open the floodgates to marijuana cultivation, distribution, and sale within the United States—allowing bad actors and transnational criminal organizations to further exploit America’s addiction crisis.”

The congressman complained that the legislation—which he called “an extreme and unwise measure”—wouldn’t impose limits on THC concentration or ban flavored cannabis products, and he said it “fails to funnel any tax revenue towards a public awareness campaign to discourage teen use of marijuana, modeled on successful anti-tobacco campaigns.”

He also claimed it “does nothing to help the Federal government and scientific community to understand the effects of marijuana usage.”

Vice President-elect Kamala Harris (D-CA) is the lead sponsor of the Senate companion version of the MORE Act.

One provision of the bill requires that any uses of the words “marijuana” or “marihuana” in U.S. Code or regulations be replaced with the term “cannabis”—despite the fact that the legislation has “marijuana” in its own title.

The Congressional Research Service released an analysis of the MORE Act last week, finding that the bill’s passage could “reverse” the current cannabis policy gap that exists between states and the federal government.

That’s because the bill does not require states to stop criminalizing cannabis, and so jurisdictions with prohibition still on the books could continue to punish people over marijuana even as such activity is legalized at the federal level.

Even if the legislation does pass in the Democratic-controlled chamber, as it’s expected to with some bipartisan support, it remains unlikely that the Senate will follow suit. Majority Leader Mitch McConnell (R-KY) is a champion of the hemp industry but staunchly opposes further marijuana reform.

That said, a symbolic vote for legalization could send a strong signal to the incoming Biden administration.

Given Biden’s former approach to championing punitive anti-drug legislation as a senator and his ongoing obstinance on marijuana legalization at a time when polls show that a clear majority of Americans favor the policy change, there remains some skepticism about his willingness to make good on his campaign promises to achieve more modest reforms he has endorsed, such as decriminalizing possession and expunging records.

A transition document the incoming Biden-Harris administration released this month left out mention of those cannabis pledges.

That said, the president-elect has conceded that his work on punitive anti-drug legislation during his time in Congress was a “mistake.”

For his part, Rep. Earl Blumenauer (D-OR) told Marijuana Moment in August that “the Biden administration and a Biden Department of Justice would be a constructive player” in advancing legalization.

These States Could Have Marijuana Legalization On Their 2022 Ballots

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

USDA Expands Hemp Crop Insurance Program For Farmers In More States

Published

on

The U.S. Department of Agriculture announced on Monday that it is expanding and improving a crop insurance program for hemp farmers.

The Multi-Peril Crop Insurance is one of several coverage programs for which hemp qualifies. Under the new expansion, farmers in certain counties of the additional states of Arizona, Arkansas, Nevada and Texas will be eligible, as will those in new counties of states already included in the program, such as Colorado, Kentucky, Michigan, Montana, New Mexico, Tennessee and Virginia.

Broker contracts for hemp grain will also be allowed for the first time, and reporting and billing dates will be adjusted to match those for similar crops.

“We are pleased to expand the hemp program and make other improvements for hemp producers,” USDA Risk Management Agency Administrator Martin Barbre said in a press release. “Hemp offers exciting economic opportunities for our nation’s farmers, and we are listening and responding to their risk management needs.”

Crop insurance policies are one of many areas USDA has acted in following hemp’s legalization through the 2018 Farm Bill.

The department has approved nearly 70 state and tribal regulatory hemp proposals and recently awarded an advocacy group $200,000 to support America’s international hemp trade.

Last month USDA closed an extended public comment period on its proposed hemp regulations after temporarily reopening the feedback period due to strong pushback from stakeholders, many of whom said the policies were too restrictive. An initial comment round saw more than 4,600 submissions.

Due to the concerns, Congress approved a continuing resolution that extends a current hemp pilot program established in 2014 through September 2021. That program, which many in the industry feel is more flexible than USDA’s proposed rules, was initially set to expire in October.

The department announced last month that it is planning to distribute a national survey to gain insights from thousands of hemp businesses that could inform its approach to regulating the industry.

Also last month, USDA issued and then rescinded guidance on providing federal loans for hemp processors.

Several members of Congress sent a letter to USDA and other federal agencies this month, telling them to better coordinate their hemp policies.

Amid the coronavirus pandemic, hemp industry associations pushed for farmers to be able to access to certain COVID-19 relief loans—a request that Congress granted in the most recent round of coronavirus legislation.

While USDA previously said that hemp farmers are specifically ineligible for its Coronavirus Food Assistance Program, that decision was reversed. While the department initially said it would not even reevaluate the crop’s eligibility based on new evidence, it removed that language shortly after Marijuana Moment reported on the exclusion.

These States Could Have Marijuana Legalization On Their 2022 Ballots

Photo courtesy of Pixabay.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!